Rifaximin’s Effect on Covert Hepatic Encephalopathy in Cirrhosis Patients With Small Intestinal Bacterial Overgrowth and Gastrointestinal Dysmotility
Condition(s):Cirrhosis, Liver; Minimal Hepatic Encephalopathy; Small Intestinal Bacterial Overgrowth; Gastrointestinal Motility DisorderLast Updated:January 28, 2020Not yet recruiting